Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

WARRANT DERIVATIVE LIABILITY

v3.22.1
WARRANT DERIVATIVE LIABILITY
3 Months Ended
Mar. 31, 2022
Warrant Derivative Liability [Abstract]  
WARRANT DERIVATIVE LIABILITY

4.WARRANT DERIVATIVE LIABILITY

The warrant derivative liability arises from Company’s common share purchase warrants in connection with historical equity offerings. These warrants are priced in non-functional currency which resulted in having exercise prices that are not fixed and include features that have a cashless exercise option or a ratchet down provision. Under IFRS 9 Financial Instruments and IAS 32 Financial Instruments: Presentation, warrants with an exercise price denominated in a currency that differs from the Company’s functional currency are treated as a derivative measured at fair value with subsequent changes in fair value accounted for through Net Loss and Comprehensive Loss. There is no cash flow impact as a result of the accounting treatment for changes in the fair value of the warrant derivative or when warrants expired unexercised.

Number of

Warrants Outstanding

Fair Value of Warrant

Derivative

As at December 31, 2021

18,955,281

4,930

Items that were classified to net loss:

Change in fair value

-

(2,909

)

As at March 31, 2022

18,955,281

2,021

As at March 31, 2022, the following derivative warrants were outstanding:

Issue Date

Expiry Date

Exercise Price

Currency

Number Issued

Number Outstanding

 

$

29-Jun-17

29-Jun-22

6.00

CAD

1,612,955

75,810

21-Jul-17

29-Jun-22

6.00

CAD

370,567

370,567

24-Aug-17

24-Aug-22

6.00

CAD

563,067

563,067

5-Dec-17

5-Dec-22

18.00

CAD

1,533,333

1,533,333

10-Apr-18

10-Apr-23

10.50

CAD

1,126,665

1,126,665

10-May-18

10-Apr-23

10.50

CAD

168,889

168,889

10-Aug-18

10-Aug-23

2.92

USD

7,679,574

6,661,068

21-Mar-19

21-Mar-24

3.95

USD

8,455,882

8,445,882

Balance at March 31, 2022

21,510,932

18,955,281